Congratulations to Paragon 28 and team for a successful IPO. The Foot & Ankle space is really hot right now. Read about Treace Medical Concepts IPO in April here. These are great comps for the orthopedic companies in the F&A space.
Press Release - Paragon 28, Inc. Announces Pricing of Initial Public Offering
Highlights - Paragon 28 plans to raise $125 million at a $1.3 billion market cap. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.
Paragon 28 (FNA) prices its initial public offering of 7.81M shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125M.
Company's common stock began trading on the NYSE on October 15, 2021, under the ticker symbol "FNA."
Offering closed on October 19, 2021
Underwriters' 30-day option to purchase up to an additional 1.17M shares.
Below is the stock price on day 1.
Here is a look back at my interview with Albert just 4 short years ago (2017). You can sense the focus and dedication from Albert.
6 Questions with Albert DaCosta, the founder of Paragon 28 who is defining the future of extremities
This ...
